Dose Escalation Study of Vinpocetine in Healthy Volunteers

PHASE1Not yet recruitingINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

June 1, 2025

Primary Completion Date

June 1, 2026

Study Completion Date

June 1, 2026

Conditions

Fetal Alcohol Spectrum Disorders

Interventions

DRUG

Vinpocetine

Increasing doses of vinpocetine to assess tolerability.

All Listed Sponsors

collaborator

National Institute on Alcohol Abuse and Alcoholism (NIAAA)

NIH

lead

Stanford University

OTHER